Evidence map›Paper›PMID 36432183›Full record

ReviewMolecules (Basel, Switzerland)2022

An Overview of Antitumour Activity of Polysaccharides.

Hongzhen Jin, Maohua Li, Feng Tian, Fan Yu, Wei Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Frontiers in nutrition · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. International journal of molecular sciences · 2024
    Article
  11. Anticancer Therapies Based on Oxidative Damage:Antioxidants (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hongzhen JinCollege of Pharmacy, Nankai University, 38 Tongyan Road, Jinnan District, Tianjin 300350, China.
Maohua LiCollege of Pharmacy, Nankai University, 38 Tongyan Road, Jinnan District, Tianjin 300350, China.
Feng TianCollege of Pharmacy, Nankai University, 38 Tongyan Road, Jinnan District, Tianjin 300350, China.
Fan YuCollege of Life Sciences, Nankai University, Weijin Road, Nankai District, Tianjin 300350, China.
Wei ZhaoCollege of Pharmacy, Nankai University, 38 Tongyan Road, Jinnan District, Tianjin 300350, China.
Nankai University · CN

Funding

National Natural Science Foundation of China 22077068the National Key R&D Program of China 2018YFA0507204
6 · The paper itself

Abstract

Cancer incidence and mortality are rapidly increasing worldwide; therefore, effective therapies are required in the current scenario of increasing cancer cases. Polysaccharides are a family of natural polymers that hold unique physicochemical and biological properties, and they have become the focus of current antitumour drug research owing to their significant antitumour effects. In addition to the direct antitumour activity of some natural polysaccharides, their structures offer versatility in synthesizing multifunctional nanocomposites, which could be chemically modified to achieve high stability and bioavailability for delivering therapeutics into tumor tissues. This review aims to highlight recent advances in natural polysaccharides and polysaccharide-based nanomedicines for cancer therapy.

Indexed as

Antineoplastic AgentsNeoplasmsHumansNanomedicinePolysaccharidesAntineoplastic AgentsPolysaccharidesanticancerdrug delivery systemsnanomedicinespolysaccharides

Identifiers

PMID36432183
PMCPMC9692906
OpenAlexW4309739645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.